# Effectiveness and Safety of Convalescent Plasma in Patients With High-risk COVID-19

> **NCT04425837** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Fundación Santa Fe de Bogota** · enrollment: 236 (estimated)

## Conditions studied

- Sars-CoV2
- Covid-19

## Interventions

- **BIOLOGICAL:** SARS-CoV-2 convalescent plasma treatment
- **OTHER:** Standard care

## Key facts

- **NCT ID:** NCT04425837
- **Lead sponsor:** Fundación Santa Fe de Bogota
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07
- **Primary completion:** 2021-02
- **Final completion:** 2021-02
- **Target enrollment:** 236 (ESTIMATED)
- **Last updated:** 2020-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04425837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04425837, "Effectiveness and Safety of Convalescent Plasma in Patients With High-risk COVID-19". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04425837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*